BIO-TECHNE Corp — Director's Dealing 2020

Nov 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-10-29

Reporting Person: Seth Alpna (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-29	Common Stock	A	391.00	$0.00	Acquired	2139.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-29	Stock Option (Right to Buy)	$255.69	A	1507.00	Acquired	2030-10-29	Common Stock (1507.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$201.64	2029-10-24	Common Stock (2011.00)	2011.00	Direct
Stock Options (Right to Buy)	$179.84	2028-10-25	Common Stock (1898.00)	1898.00	Direct
Stock Options (Right to Buy)	$125.05	2027-10-26	Common Stock (3125.00)	3125.00	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne 2021 annual meeting of shareholders.